George Laskaris and Alma Villasin have joined Frontage Laboratories in senior positions. Laskaris has been named senior director, Frontage Biometrics Services, and Villasin, R.N., B.S.N., M.B.A., joins as director, clinical operations.

Laskaris brings more than 20 years of programming, statistical and data management experience within pharmaceutical and CROs. He will spearhead operational management, infrastructure development and growth strategies for Frontage’s clinical programming, statistics and data management groups. Laskaris joins Frontage from PRA, where he managed a team of statistical programmers.

Villasin will be responsible for day-to-day oversight of clinical operations and staff training for all study activities and for oversight of the company’s clinical operations expansion initiative. Most recently, Villasin was clinical operations director for Duke Clinical Research Unit (DCRU), where she oversaw the feasibility and conduct of phase I-III clinical trials. Prior to DCRU, she worked at Thomas Jefferson University as manager of the clinical trials groups. She led a research collaboration on global cardiovascular phase II/III trials and developed an investigator network in key therapeutic areas such as cardiovascular, endocrinology and family medicine.

The addition of these two positions is part of Frontage’s strategy to expand its full-service early phase clinical services, which include capabilities to conduct a broad range of  studies  as well as broadening protocol development, analysis methodology and reporting services supporting later phase trials and programs.